Company sells 10% debentures; each is convertible at $11.75 per share
By Devika Patel
Knoxville, Tenn., July 25 – Medbox, Inc. negotiated a $3 million private placement of convertible debentures on July 21, according to an 8-K filed Friday with the Securities and Exchange Commission. The convertibles will be sold in three equal tranches of $1 million each and the company has already completed the first tranche.
The 10% debenture is convertible into common shares at $11.75 per share. The conversion price is a 28.09% discount to the July 18 closing share price of $16.34.
The West Hollywood, Calif., company offers a machine that dispenses medication to individuals based on biometric identification.
| Issuer: | Medbox, Inc.
|
| Issue: | Convertible debentures
|
| Amount: | $3 million
|
| Coupon: | 10%
|
| Conversion price: | $11.75
|
| Warrants: | No
|
| Pricing date: | July 21
|
| Settlement date: | July 21 (for $1 million)
|
| Stock symbol: | OTCBB: MDBX
|
| Stock price: | $16.34 at close July 18
|
| Market capitalization: | $466.37 million
|
|
|
© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere.
For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.
